Related Experiment Videos
[Lymphocytic hypophysitis: a report of 3 cases]
Zhao-hui Lü1, Ju-ming Lu, Wen-sheng Jin
1Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China.
Zhonghua Nei Ke Za Zhi
|July 13, 2005
Summary
Lymphocytic hypophysitis is a rare autoimmune pituitary disorder. High-dose methylprednisolone pulse therapy effectively treats this condition, reducing pituitary mass and restoring function.
Area of Science:
- Endocrinology
- Neuroimmunology
- Pathology
Background:
- Lymphocytic hypophysitis (LYH) is a rare inflammatory condition affecting the pituitary gland.
- It is considered an autoimmune endocrinopathy, often presenting in young women, particularly during the postpartum period.
Observation:
- This study reports on three cases of LYH, analyzing their clinical data.
- Common symptoms include pituitary hypofunction, headache, and diabetes insipidus.
- Pituitary MRI typically shows an enhanced mass with stalk enlargement, compressing surrounding structures.
Findings:
- Histopathology reveals extensive lymphocytic infiltration and destruction of anterior pituitary acini.
- Two of the three patients experienced successful treatment with high-dose methylprednisolone pulse therapy (HDMPT).
- Treatment led to pituitary mass reduction and restoration of pituitary function.
Implications:
- LYH can mimic pituitary adenoma, necessitating accurate diagnosis.
- HDMPT is an effective therapeutic strategy for LYH, offering significant clinical improvement.
- Further research into autoimmune hypophysitis is warranted to improve understanding and management.